Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

32
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
32
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

679
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
679
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

549
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
549
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

409
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
409
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

1.4K
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.4K
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

682
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
682

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating Patient Safety and Efficacy of Robot-Assisted Adrenalectomy: 90-Day Outcomes.

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP·2026
Same author

Post-transplant metabolic dysregulation: Insights and implications for kidney graft survival.

World journal of nephrology·2026
Same author

Lupus nephritis and kidney transplantation: A narrative review of patient and graft outcomes.

World journal of nephrology·2026
Same author

Male infertility in lupus nephritis: Clinical implications and management strategies.

Lupus·2026
Same author

IgA-Dominant Idiopathic Membranoproliferative Glomerulonephritis: Insights into Clinicopathological Characteristics and Kidney Outcomes in a Developing Country.

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2026
Same author

Hypoalbuminemia as a predictor of mortality in patients with acute cholangitis: A systematic review and meta-analysis.

World journal of gastrointestinal pathophysiology·2026

Related Experiment Video

Updated: May 2, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

1.1K

IgM nephropathy; time to act.

Muhammed Mubarak1

  • 1Department of Histopathology, Sindh Institute of Urology and Transplantation (SIUT), Karachi, Pakistan.

Journal of Nephropathology
|March 20, 2014
PubMed
Summary

IgM nephropathy research needs more focus on its causes, development, and treatments. International collaboration is crucial for advancing understanding and defining this kidney disease.

Area of Science:

  • Nephrology
  • Immunology
  • Pathology

Background:

  • Extensive literature exists on IgM nephropathy epidemiology and clinicopathology.
  • Significant knowledge gaps remain regarding etiology, pathogenesis, and specific therapies.
  • The definition and nosologic status of IgM nephropathy are subjects of ongoing debate.

Purpose of the Study:

  • To highlight the need for further research into IgM nephropathy.
  • To emphasize the current limitations in understanding the disease's origins and treatment.
  • To call for international collaboration to address these research gaps.

Main Methods:

  • Literature review and synthesis of existing knowledge on IgM nephropathy.
  • Identification of key areas requiring further investigation.
Keywords:
IgA nephropathyIgM nephropathyMinimal change disease

More Related Videos

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

1.8K
Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
08:15

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Published on: May 10, 2024

1.1K

Related Experiment Videos

Last Updated: May 2, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

1.1K
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

1.8K
Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
08:15

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Published on: May 10, 2024

1.1K
  • Analysis of the current state of research and clinical understanding.

    • Main Results:

    • Epidemiological and clinicopathological data are relatively well-documented.
    • Etiology, pathogenesis, and specific therapeutic strategies for IgM nephropathy are poorly understood.
    • The classification and definition of IgM nephropathy lack universal consensus.

    Conclusions:

    • Further progress in understanding IgM nephropathy requires addressing fundamental questions about its cause and treatment.
    • International cooperation among researchers is essential for advancing the field.
    • Clarifying the definition and nosologic status is critical for future research and clinical practice.